UFP TECHNOLOGIES INC
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No enriched coverage for $UFPT in the last 7 days.
UFP Technologies, Inc. (UFPT) completed the acquisition of CI Medical Inc. on September 7, 2026. The company's stock has seen a 5-day change of 288.79 USD, a 1st Jan change of +0.79%, and a year-to-date change of +30.07%.
UFP Technologies (UFPT) reported record Q2 profits of $20.9M, up 21.4% YoY, with net sales of $174.0M, up 15.1%. Gross margin rose to 29.3%, but SG&A expenses increased 21.8%, raising concerns. CEO noted near-term margin pressure due to Dominican Republic operations. Hedge fund interest declined, and short interest is high at 19.26% of float.
UFP Technologies (UFPT) aims for 12%-18% annual growth via organic growth and acquisitions, targeting medical device markets. The company expects gross margins of 28%-31% and operating margins of 17%-20%. UFP is evaluating 5-10 acquisition opportunities with EBITDA ranging from $5M to $30M. Inventory is expected to decline in Q4 due to seasonal factors.
Recent UFPT coverage spans insider activity, earnings and mergers & acquisitions.
In the last 30 days, UFPT insiders filed 2 SEC Form 4 transactions — no purchases and 2 sales ($2.1M). The most active reporter was KOZIN MARC D with 2 filings.
The deal adds CI Medical's products to UFP's portfolio, potentially expanding market reach and revenue.
Earnings beat on revenue and margin expansion may support upside, but SG&A growth and cash burn raise downside risk, especially with 19% short interest.
Guidance suggests strong top‑line growth and potential acquisition‑driven expansion.
UFP Technologies director Marc D. Kozin sold 6,975 shares in two transactions, averaging $304.52 per share, totaling $2.13M. Kozin now owns 21,112 shares. The sales were reported in an SEC Form 4 filing.
The insider sale may signal reduced confidence, potentially pressuring the stock short term.
AlphAI scores every news story that mentions UFPT with an AI model for sentiment and relevance, and aggregates insider trades from UFP TECHNOLOGIES INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
UFP Technologies, Inc. (UFPT) completed the acquisition of CI Medical Inc. on September 7, 2026. The company's stock has seen a 5-day change of 288.79 USD, a 1st Jan change of +0.79%, and a year-to-date change of +30.07%.
1 min readUFP Technologies (UFPT) reported record Q2 profits of $20.9M, up 21.4% YoY, with net sales of $174.0M, up 15.1%. Gross margin rose to 29.3%, but SG&A expenses increased 21.8%, raising concerns. CEO noted near-term margin pressure due to Dominican Republic operations. Hedge fund interest declined, and short interest is high at 19.26% of float.
3 min readUFP Technologies (UFPT) aims for 12%-18% annual growth via organic growth and acquisitions, targeting medical device markets. The company expects gross margins of 28%-31% and operating margins of 17%-20%. UFP is evaluating 5-10 acquisition opportunities with EBITDA ranging from $5M to $30M. Inventory is expected to decline in Q4 due to seasonal factors.
2 min readUFP Technologies director Marc D. Kozin sold 6,975 shares in two transactions, averaging $304.52 per share, totaling $2.13M. Kozin now owns 21,112 shares. The sales were reported in an SEC Form 4 filing.
1 min readKOZIN MARC D sold 7,000 shares of UFP TECHNOLOGIES INC (UFPT) at an average of $304.50 ($303.97–$305.07, $2.13M total) across 2 trades on 2026-08-25.
1 min readHudson Symeria sold 1,926 shares of UFP TECHNOLOGIES INC (UFPT) at $324.58 ($0.63M total) on 2026-08-14.
1 min readFELDMANN CYNTHIA L sold 1,000 shares of UFP TECHNOLOGIES INC (UFPT) at $324.26 ($0.32M total) on 2026-08-13.
2 min readBAILLY R JEFFREY (Executive Chairman) sold 13,011 indirectly-held shares of UFP TECHNOLOGIES INC (UFPT) at an average of $316.13 ($315.53–$317.27, $4.11M total) across 3 trades on 2026-08-10.
1 min readUFP Technologies (UFPT) reported Q2 2026 net sales of $174 million, up 15.1%, with organic sales growth of 12.4%. Adjusted EPS rose 16.8% to $2.92 and gross margin increased to 29.3%. Adjusted EBITDA was $36.4 million. Management cited MedTech strength, low leverage under 1x, and an acquisition pipeline of 5 to 10 opportunities.
6 min readBAILLY R JEFFREY (Executive Chairman) sold 15,695 indirectly-held shares of UFP TECHNOLOGIES INC (UFPT) at an average of $318.38 ($315.06–$320.05, $5.00M total) across 4 trades over 2026-08-06 to 2026-08-07.
2 min read
